ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.210
-0.100 (-4.33%)
At close: Mar 3, 2026, 4:00 PM EST
2.240
+0.030 (1.36%)
After-hours: Mar 3, 2026, 7:58 PM EST
ProKidney Market Cap
ProKidney has a market cap or net worth of $664.84 million as of March 3, 2026. Its market cap has increased by 42.46% in one year.
Market Cap
664.84M
Enterprise Value
397.35M
1-Year Change
42.46%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $664.84M, an increase of 156.89%. That is a compound annual growth rate of 22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 694.90M | 3.12% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 711.63M |
| Jade Biosciences | 682.24M |
| Alpha Tau Medical | 648.01M |
| Vor Biopharma | 646.05M |
| enGene Holdings | 637.07M |
| Rigel Pharmaceuticals | 632.94M |
| Zura Bio | 621.43M |
| YD Bio | 620.92M |